Mail Outreach To Increase Vaccination Acceptance Through Engagement
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 228,000
- 试验地点
- 2
- 主要终点
- Number of study participants who receive influenza vaccination
研究概览
简要总结
The aim of this study is to determine whether receiving a core letter signed by the Surgeon General or the Director of the National Vaccine Program that provides only information about influenza, or a core letter signed by the Surgeon General with an added basic or enhanced implementation prompt, will increase rates of influenza vaccination among Medicare beneficiaries when compared to a control group.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 66 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
No letter
Individuals randomized to the control group who will not receive any of the four letters
Core letter signed by Surgeon General
Individuals randomized to receive only a core letter signed by the Surgeon General
干预措施: Core letter signed by Surgeon General (Behavioral)
Core letter signed by Director of the National Vaccine Program
Individuals randomized to receive only a core letter signed by the Director of the National Vaccine Program
干预措施: Core letter signed by the Director of the National Vaccine Program (Behavioral)
Core letter signed by Surgeon General + implementation prompt
Individuals randomized to receive a core letter signed by the Surgeon General with an implementation intention prompt added in an appended P.S. tag region below the signature line
干预措施: Core letter signed by Surgeon General + implementation prompt (Behavioral)
Core letter signed by SG + enhanced implementation prompt
Individuals randomized to receive a core letter signed by the Surgeon General (SG) with an enhanced implementation intention prompt added in an appended P.S. tag region below the signature line
干预措施: Core letter signed by SG + enhanced implementation prompt (Behavioral)
结局指标
主要结局
Number of study participants who receive influenza vaccination
时间窗: 4 months
Primary outcome of interest, determined from administrative claims data, will be the number of beneficiaries in each experimental group who receive an influenza vaccination between the date letter is mailed in September 2014 and January 31, 2015
次要结局
未报告次要终点
研究者
Niteesh K. Choudhry, MD, PhD
Associate Professor, Harvard Medical School
Brigham and Women's Hospital